Effectdossier · gearchiveerd kwartaal
CVS
CVS Health Corp. · Healthcare · Medical - Healthcare Plans
22Gevolgde houders
—Δ houders
197.40MGehouden aandelen
$11.65BGerapporteerde waarde
+0Nieuwe posities
−0Uitstappen
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2024
Eigendom in de tijd
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 183 | +1 | 959.19M | $98.99B | +4 | −2 |
| Q1 2026 | 184 | -5 | 933.53M | $67.00B | +1 | −7 |
| Q4 2025 | 188 | -1 | 988.04M | $78.39B | +1 | −1 |
| Q3 2025 | 31 | +1 | 672.14M | $50.66B | +1 | −1 |
| Q2 2025 | 28 | +1 | 592.40M | $40.85B | +1 | — |
| Q1 2025 | 24 | 0 | 305.08M | $20.66B | +1 | −1 |
| Q4 2024 | 24 | -1 | 290.03M | $13.02B | +1 | −2 |
| Q3 2024 | 24 | +2 | 213.06M | $13.39B | +3 | −1 |
| Q2 2024 | 22 | — | 197.40M | $11.65B | — | — |
Wie het bezit · Q2 2024
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox ✦ | 61.68M | — | $3.64B | 2.2% | n/c | 1 | SEC ↗ |
| 2 | Capital World Investors ✦ | 56.02M | — | $3.31B | 0.5% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passief) | 25.90M | — | $1.53B | 0.1% | n/c | 1 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passief) | 25.90M | — | $1.53B | 0.1% | n/c | 1 | SEC ↗ |
| 5 | Norges Bank ✦ (passief) | 14.90M | — | $880.06M | 0.1% | n/c | 1 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 10.24M | — | $604.56M | 0.1% | n/c | 1 | SEC ↗ |
| 7 | T. Rowe Price ✦ | 10.24M | — | $604.56M | 0.1% | n/c | 1 | SEC ↗ |
| 8 | Glenview Capital ✦ | 9.16M | — | $541.13M | 11.5% | n/c | 1 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 5.29M | — | $310.72M | 0.5% | n/c | 1 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 5.29M | — | $310.72M | 0.5% | n/c | 1 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 5.29M | — | $310.72M | 0.5% | n/c | 1 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 5.29M | — | $310.72M | 0.5% | n/c | 1 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 5.29M | — | $310.72M | 0.5% | n/c | 1 | SEC ↗ |
| 14 | Harris Associates (Oakmark) ✦ | 4.73M | — | $279.26M | 0.5% | n/c | 1 | SEC ↗ |
| 15 | Harris Associates (Oakmark) ✦ | 4.73M | — | $279.26M | 0.5% | n/c | 1 | SEC ↗ |
| 16 | PRIMECAP Management ✦ | 3.36M | — | $198.58M | 0.1% | n/c | 1 | SEC ↗ |
| 17 | Arrowstreet Capital ✦ | 1.82M | — | $107.56M | 0.1% | n/c | 1 | SEC ↗ |
| 18 | Bridgewater Associates ✦ | 1.24M | — | $73.45M | 0.4% | n/c | 1 | SEC ↗ |
| 19 | D. E. Shaw & Co. ✦ | 1.08M | — | $63.80M | 0.1% | n/c | 1 | SEC ↗ |
| 20 | D. E. Shaw & Co. ✦ | 1.08M | — | $63.80M | 0.1% | n/c | 1 | SEC ↗ |
| 21 | Millennium Management ✦ | 636.90K | — | $37.62M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Adage Capital Partners ✦ | 351.56K | — | $20.76M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Wellington Management ✦ | 211.13K | — | $12.47M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Wellington Management ✦ | 211.13K | — | $12.47M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Wellington Management ✦ | 211.13K | — | $12.47M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Wellington Management ✦ | 211.13K | — | $12.47M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | GAMCO Investors ✦ | 167.21K | — | $9.88M | 0.1% | n/c | 1 | SEC ↗ |
| 28 | Gotham Asset Management ✦ | 145.92K | — | $8.62M | 0.1% | n/c | 1 | SEC ↗ |
| 29 | Citadel Advisors ✦ | 144.11K | — | $8.51M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Two Sigma Investments ✦ | 97.45K | — | $5.76M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Marshall Wace ✦ | 90.73K | — | $5.36M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Marshall Wace ✦ | 90.73K | — | $5.36M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Marshall Wace ✦ | 90.73K | — | $5.36M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | Fisher Asset Management ✦ | 73.70K | — | $4.35M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Markel Group ✦ | 47.00K | — | $2.78M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Markel Group ✦ | 47.00K | — | $2.78M | 0.0% | n/c | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1,848 houders, 1.07B aandelen, $73.55B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Vaak gezamenlijk in bezit
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR.
Rapportageperiode: Q2 2024 ·
Methodologie ·
Verkrijg dit via de API